FOS and infection: Even though inhibition of the MEK/ERK pathway had resulted in a significant decrease in AP-1 activation by B14, there was no difference in the levels of activated ERK1/2 in the absence of B14 during the infection (Fig. 3b, lanes 2 and 3).